sk&f 99085 has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentzen, C; Bonate, PL; Floret, S | 1 |
| Alberts, DS; Bentzen, CL; Floret, S; Garcia, DJ; Gleason-Guzman, M; Hallum, AV; Niesor, EJ; Salmon, SE; Santabarbara, P; Stratton-Custis, M | 1 |
1 review(s) available for sk&f 99085 and Neoplasms
| Article | Year |
|---|---|
Population pharmacokinetics of APOMINE: a meta-analysis in cancer patients and healthy males.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diphosphonates; Female; Humans; Male; Middle Aged; Models, Chemical; Monte Carlo Method; Neoplasms | 2004 |
1 trial(s) available for sk&f 99085 and Neoplasms
| Article | Year |
|---|---|
Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug.
Topics: Administration, Oral; Antineoplastic Agents; Cell Division; Diphosphonates; Drug Screening Assays, Antitumor; Female; Humans; Male; Neoplasms; Tumor Cells, Cultured | 2001 |